Filing Details

Accession Number:
0001181431-10-005140
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-28 12:00:00
Reporting Period:
2010-01-27
Filing Date:
2010-01-28
Accepted Time:
2010-01-28 15:37:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1295976 Cellu Tissue Holdings Inc. CLU Paper Mills (2621) 061346495
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1480567 D Steven Ziessler 1855 Lockeway Drive
Suite 501
Alpharetta GA 30004
Pres. Tissue & Mach-Gl, Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-01-27 137,426 $0.00 137,426 No 4 C Direct
Common Stock Acquisiton 2010-01-27 18,327 $0.00 155,753 No 4 C Direct
Common Stock Acquisiton 2010-01-27 225,640 $0.00 381,393 No 4 C Direct
Common Stock Disposition 2010-01-27 123,841 $13.00 257,552 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2010-01-27 137,426 $0.00 137,426 $0.00
Common Stock Series B Preferred Stock Disposition 2010-01-27 18,327 $0.00 18,327 $0.00
Common Stock Common Stock Disposition 2010-01-27 225,640 $0.00 225,640 $0.00
Common Stock Employee Stock Option Disposition 2010-01-27 138,662 $0.00 138,662 $5.28
Common Stock Employee Stock Option Acquisiton 2010-01-27 138,662 $0.00 138,662 $5.28
Common Stock Employee Stock Option Acquisiton 2010-01-27 45,878 $0.00 45,878 $11.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 2019-04-13 No 4 J Direct
138,662 2019-04-13 No 4 J Direct
45,878 2020-01-27 No 4 A Direct
Footnotes
  1. Series A Preferred Stock of Cellu Parent Corporation was converted into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation was merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
  2. Series B Preferred Stock of Cellu Parent Corporation was converted into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation was merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
  3. Reporting person was granted shares of Restricted Stock in Cellu Parent Corporation on June 12, 2006, of which 75% had vested. Pursuant to the terms of the reorganization transactions that were consummated in connection with the Issuer's initial public offering and upon the closing of the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation Common Stock was exchanged for fully vested shares of Issuer Common Stock.
  4. Reporting person held an option to purchase shares of Common Stock in Cellu Parent Corporation. Pursuant to the terms of the reorganization transactions that were consummated in connection with the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation options were exchanged for options to purchase Issuer Common Stock.
  5. Upon the closing of the Issuer's initial public offering and on the date of the exchange, options to purchase 45,024 shares became fully vested and options for the remaining shares will vest as to 33.33% of the shares each year beginning on the first anniversary date of the closing of the Issuer's initial public offering.
  6. Stock option grant under the Issuer's 2010 Equity Compensation Plan. Vests in four equal installments annually beginning on January 27, 2011.